至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Homozygous and heterozygous point mutations in succinate dehydrogenase subunits b, c, and d of Rhizoctonia cerealis conferring resistance to thifluzamide.

Pest Manag Sci.. 2017-05; 
Sun HY, Lu CQ, Li W, Deng YY, Chen HG.
Products/Services Used Details Operation
PCR Cloning and Subcloning ... and purified using a DNA Gel Extraction Kit (Axygen, Union City, CA, USA). Purified PCR products were sequenced by Genscript Co., Ltd (Nanjing, China). Sequences were assembled and further aligned with Vector NTI and BioEdit software. To assure the ... Get A Quote

摘要

BACKGROUND: Thifluzamide, a succinate dehydrogenase inhibitor (SDHI) fungicide, is a promising fungicide for controlling wheat sharp eyespot (WSE). WSE is caused by Rhizoctonia cerealis. Information on the resistance mechanism of this pathogen to thifluzamide remains unavailable. RESULTS: We used selective reculturing and UV mutagenesis to generate thifluzamide-resistant mutants. Thifluzamide-resistant mutants were only generated through UV mutagenesis. Sequence analysis of succinate dehydrogenase (Sdh) genes revealed that two mutants had no mutation in RCSdhB, RCSdhC and RCSdhD, and the other 18 mutants all had at least one mutation in RCSdhB, RCSdhC or RCSdhD, either in a homozygous or heterozygous state. The... More

关键词

Rhizoctonia cerealis; SDHI resistance; homozygous and heterozygous mutation; thifluzamide